BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20594120)

  • 1. Vitamin D, NOD2, autophagy and Crohn's disease.
    Verway M; Behr MA; White JH
    Expert Rev Clin Immunol; 2010 Jul; 6(4):505-8. PubMed ID: 20594120
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
    Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
    Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities in the handling of intracellular bacteria in Crohn's disease: a link between infectious etiology and host genetic susceptibility.
    Glasser AL; Darfeuille-Michaud A
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):237-44. PubMed ID: 18726145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling pathways and molecular interactions of NOD1 and NOD2.
    Strober W; Murray PJ; Kitani A; Watanabe T
    Nat Rev Immunol; 2006 Jan; 6(1):9-20. PubMed ID: 16493424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells.
    Okumura S; Yuki K; Kobayashi R; Okamura S; Ohmori K; Saito H; Ra C; Okayama Y
    Clin Immunol; 2009 Feb; 130(2):175-85. PubMed ID: 18938111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How NOD2 and autophagy may be related to Crohn's disease? A view shifted from live microbes to luminal bacterial debris.
    Qin X
    J Crohns Colitis; 2014 Jan; 8(1):88. PubMed ID: 23969121
    [No Abstract]   [Full Text] [Related]  

  • 9. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
    Press RD
    Mol Diagn; 2001 Dec; 6(4):347-8. PubMed ID: 11837220
    [No Abstract]   [Full Text] [Related]  

  • 10. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
    Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
    Philpott DJ; Viala J
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD2 and Crohn's disease: loss or gain of function?
    Eckmann L; Karin M
    Immunity; 2005 Jun; 22(6):661-7. PubMed ID: 15963781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARD15 and Crohn's disease.
    Peters KE; Cavanaugh JA
    J Gastroenterol Hepatol; 2004 Jul; 19(7):830. PubMed ID: 15209636
    [No Abstract]   [Full Text] [Related]  

  • 14. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.
    Watanabe T; Kitani A; Strober W
    Gut; 2005 Nov; 54(11):1515-8. PubMed ID: 16227353
    [No Abstract]   [Full Text] [Related]  

  • 16. Normal responses to specific NOD1 ligands.
    Ferwerda G; Girardin SE; van der Meer JW; Netea MG
    Eur J Immunol; 2006 Oct; 36(10):2817-8; author reply 2818. PubMed ID: 17013977
    [No Abstract]   [Full Text] [Related]  

  • 17. Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?
    Rogler G; Holler E
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):62-3. PubMed ID: 16265048
    [No Abstract]   [Full Text] [Related]  

  • 18. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
    Wang G; Stange EF; Wehkamp J
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic lymphoid follicles and NOD2/CARD15 mutational status in Crohn's disease.
    Nascimbeni R; Villanacci V; Bassotti G; Fisogni S; Gervasi M; Rossi E; Di Lorenzo D
    Br J Surg; 2009 Jun; 96(6):655-62. PubMed ID: 19434699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.